Crush or swallow? new study tests best way to take diabetes drug empagliflozin
NCT ID NCT06962826
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This completed Phase 1 trial in 14 healthy adults tested how the diabetes drug empagliflozin enters the body when taken as a whole tablet or dissolved in water and mixed with food. Researchers measured drug levels in the blood to compare absorption. The study aims to guide how the medication should be taken for best effect.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- empagliflozin
- What this could lead to
- If successful, this study could help doctors understand the best way to take empagliflozin for optimal absorption.
- What could go wrong
- This is a very small, early-phase study in healthy volunteers, so results may not apply to patients with diabetes or other conditions.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Humanpharmakologisches Zentrum Biberach
Biberach, 88397, Germany
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a new oral drug change future treatments? early safety trial begins
- Can brain scans unlock the secret to hearing in crowded rooms?
- Can a Light-Guided device make arterial sticks easier?
- Water workouts could be the key to back pain relief
- Could everyday disinfectants be harming us? a new study investigates
- Can a new drug keep the Heart's beat steady? trial puts verducatib to the test